Center Laboratories Inc. manufactures and markets oral liquid formulations and children's formulations.  The Company is focusing on the development of respiratory care and pain relief products.

Announcement Of The Date Of The Board Meeting For
The Company'S 2024 Q3 Financial Report.

Announcement That The Company’S Board Of
Directors Resolved To Issue The 1st Employee Stock
Options (Esos) In 2024

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Center Laboratories (4123 TT)

Announcement Of The Date Of The Board Meeting For The Company'S 2024 Q3 Financial Report.

Announcement That The Company’S Board Of Directors Resolved To Issue The 1st Employee Stock Options (Esos) In 2024

The Announcement Of The Company'S Board Resolution To Participate In The Cash Capital Increase Of Lumosa Therapeutics Co.,Ltd.

Announcement On Behalf Of Subsidiary, Centerlab Hk, The Disposal Of Bioflag Ky Shares

Announcement On The Acquisition Of Bioflag International Corporation (Cayman) Stock

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)